Aducanumab

Drop in Covid sales, trial failures, restructuring trigger steep rise in layoffs in Q1 2023

Since 2022, layoffs have become commonplace. The ongoing global banking crisis, coupled with pre-exi

America’s drug price hike conundrum in backdrop of 2019 Medicare Part D data

Nearly every year, drugmakers ring in the new year with drug price increases in the US. This year